Geeta Gupta, MD
Internal Medicine · Lakewood, NJNPI 1659383651
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $7,777 of the $9,093 with a category attached, or 85.5%. It is spread thinly across 39 manufacturers, the largest accounting for just 14.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,122 and has fallen 77.0% since, to $488 in 2025. Among internal medicine clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 422 payments — averaging $21.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cvrx, Inc.$1K
- Boston Scientific$1K
- Amgen$773
- Abbott$736
- Johnson & Johnson$702
- Boehringer Ingelheim$520
- plus $4K from 33 others
What the payments were for
- Travel & lodging$1,31614%
- Food & beverage$7,77786%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cvrx, Inc. | 8 | $1,309 |
| Boston Scientific | 23 | $1,208 |
| Amgen | 61 | $773 |
| Abbott | 32 | $736 |
| Johnson & Johnson | 45 | $702 |
| Boehringer Ingelheim | 31 | $520 |
| Amarin Pharma, Inc. | 22 | $514 |
| Philips North America LLC | 38 | $480 |
| Novo Nordisk | 25 | $381 |
| E.r. Squibb & Sons, L.L.C. | 5 | $280 |
| Merck | 18 | $258 |
| Corcept Therapeutics | 16 | $248 |
| Novartis | 8 | $171 |
| Kowa Pharmaceuticals America, Inc. | 11 | $150 |
| Silk Road Medical, Inc. | 1 | $122 |
| Pfizer | 8 | $114 |
| Edwards Lifesciences | 6 | $109 |
| Medicomp Inc | 6 | $99 |
| Lexicon Pharmaceuticals, Inc. | 6 | $98 |
| Kiniksa Pharmaceuticals, Ltd. | 6 | $92 |
| AstraZeneca(2 entities) | 5 | $74 |
| Regeneron Healthcare Solutions, Inc. | 5 | $71 |
| Digirad Health, Inc | 1 | $55 |
| Arbor Pharmaceuticals, Inc. | 3 | $55 |
| Sanofi-aventis U.S. LLC | 4 | $53 |
| Esperion Therapeutics, Inc. | 4 | $49 |
| Sanofi Pasteur Inc. | 3 | $44 |
| Heartflow, Inc. | 2 | $44 |
| GSK | 3 | $42 |
| Astellas Pharma US Inc | 3 | $41 |
| Vital Connect, Inc | 2 | $36 |
| Chiesi USA, Inc. | 2 | $31 |
| Scpharmaceuticals Inc. | 2 | $30 |
| Preventice Services, LLC | 2 | $28 |
| G Medical Diagnostic Services, Inc. | 1 | $17 |
| Lilly USA, LLC | 1 | $17 |
| Daiichi Sankyo Inc. | 1 | $15 |
| Xeris Pharmaceuticals, Inc. | 1 | $13 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Barostim Neo System$1,036
- Watchman$926
- Vascepa$242
- CAMZYOS$241
- ENROUTE Transcarotid Neuroprotection System$122
- ENROUTE Transcarotid Stent$122
- JARDIANCE$100
How this compares
$9,093 in reported general payments places this provider in the 90th percentile of 4,032 internal medicine providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Valsartan-HydrochlorothiazideValsartan/Hydrochlorothiazide | 18 | $847 |
| Levothyroxine Sodium | 57 | $683 |
| Rosuvastatin Calcium | 31 | $377 |
| Amlodipine Besylate | 52 | $353 |
| Pantoprazole Sodium | 17 | $321 |
| Losartan Potassium | 23 | $170 |
| Metoprolol Succinate | 15 | $166 |
| Metformin Hcl | 27 | $146 |
| Lisinopril | 14 | $123 |
| Atorvastatin Calcium | 33 | $114 |
| Citalopram HbrCitalopram Hydrobromide | 11 | $98 |
| Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid | 13 | $85 |
| Azithromycin | 16 | $34 |
| Alprazolam | 14 | $17 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Lakewood
- Howard UdermanLakewood$955K
- Joseph MorelosLakewood$30K
- David ShulkinMorristown$1.7M
- Darshi SunderamEast Orange$530K
- Annika DrongeEmerson$401K
- Stephen MarcellaNew Brunswick$331K
- Viju VijaysadanKinnelon$325K
- Mark MonaneWoodcliff Lake$268K
- Martin BedigianLivingston$240K
- Rameck HuntPlainsboro$217K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.